GlassScriptPhysician profile
Sara D Madden
NPI 1851776736
$3,561.35
in general payments reported to CMS, 2019-2025
11 companies · $606 in 2025
The $606 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $143 · 2021: $761 · 2022: $678 · 2023: $612 · 2024: $612 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,829.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,753.55 | 2019-2025 | Precision 1, Total30, Dailies |
| Bausch & Lomb Americas INC. | $175.74 | 2022-2024 | Biotrue One Day, Infuse |
| Optos, INC. | $151.01 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $132.17 | 2021-2023 | Cequa |
| Coopervision INC. | $115.62 | 2019-2023 | Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $68.68 | 2024 | Contact Lens, Spectacle Lenses |
| Allergan, INC. | $67.41 | 2022 | |
| Lombart Brothers, INC. | $34.49 | 2025 | Opd-III |
| Dompe US, INC. | $27.90 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.